Next Article in Journal
Indications for Hyperthermic Intraperitoneal Chemotherapy with Cytoreductive Surgery: A Clinical Practice Guideline
Previous Article in Journal
Inflammatory Markers as Prognostic Factors of Recurrence in Advanced-Stage Squamous Cell Carcinoma of the Head and Neck
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on as a courtesy and upon agreement with Multimed Inc..
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:

Management of Dyspnea in Palliative Care

Department of Family Medicine, Western University, London, ON, Canada
Author to whom correspondence should be addressed.
Curr. Oncol. 2020, 27(3), 142-145;
Received: 3 March 2020 / Revised: 5 April 2020 / Accepted: 7 May 2020 / Published: 1 June 2020


Dyspnea is a symptom commonly experienced by cancer patients that causes significant suffering, worsens throughout a patient’s disease trajectory, and can be more difficult to manage than other symptoms. Assessment of dyspnea is best accomplished by a subjective description; physiologic measures are only weakly correlated with the patient’s experience. It is important to consider a wide range of possible malignant and nonmalignant causes of dyspnea in cancer patients and to correct underlying causes where possible. For patients with refractory dyspnea, opioids are a safe and effective treatment. Benzodiazepines can be considered, but the evidence for their use is weak. Supplemental oxygen is beneficial if patients are hypoxemic, or if they have concurrent chronic obstructive pulmonary disease. Nonpharmacologic strategies such as fan therapy, exercise programs, and pulmonary rehabilitation can also be beneficial. One important diagnosis to consider in all cancer patients is venous thromboembolism. Prompt evaluation and treatment are vital to improving symptoms and outcomes for patients. Although dyspnea is common and potentially debilitating in cancer patients, it can be effectively managed with a structured approach to rule out reversible causes while concurrently treating the patient using appropriate therapeutic strategies.
Keywords: dyspnea; supplemental oxygen; opioids; venous thromboembolism dyspnea; supplemental oxygen; opioids; venous thromboembolism

Share and Cite

MDPI and ACS Style

Crombeen, A.M.; Lilly, E.J. Management of Dyspnea in Palliative Care. Curr. Oncol. 2020, 27, 142-145.

AMA Style

Crombeen AM, Lilly EJ. Management of Dyspnea in Palliative Care. Current Oncology. 2020; 27(3):142-145.

Chicago/Turabian Style

Crombeen, A.M., and E.J. Lilly. 2020. "Management of Dyspnea in Palliative Care" Current Oncology 27, no. 3: 142-145.

Article Metrics

Back to TopTop